Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI scoreYuya Iwamoto, Takahiro Kimura, Aaron M. Potretzke et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 5
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched CohortTatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto et al.|The Prostate|2025Cited by 3
The prognostic significance of additional localized treatment to primary lesion in patients undergoing hormone therapy for metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisYuta Yamada, Haruki Kume, Fumihiko Urabe et al.|PLoS ONE|2024Cited by 3
Clinical utility of a novel perioperative quality assessment metric, trifecta, for radical cystectomyMahito Atsuta, Jun Miki, Fumihiko Urabe et al.|International Journal of Clinical Oncology|2025Cited by 2
Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomesShun Saito, On behalf of JIKEI-SCRUM Collaborative Group, Hidetsugu Takahashi et al.|Japanese Journal of Clinical Oncology|2024Cited by 1